Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference26 articles.
1. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: the Japan Clinical Oncology Group study (JCOG 9205);Ohtsu;J Clin Oncol,2003
2. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study;Boku;Lancet Oncol,2009
3. S-1 plus cisplatin versus S-1 alone for first-line treatment of ad- vanced gastric cancer (SPIRITS trial): a phase III trial;Koizumi;Lancet Oncol,2008
4. Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with paraaortic lymph node metastases;Fushida;Anticancer Drugs,2009
5. Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer;Sato;Cancer Chemother Pharmacol,2010
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Survival benefits of gastrectomy in patients with metastatic gastric cancer: A meta-analysis;Advances in Clinical and Experimental Medicine;2024-06-11
2. Minimally Invasive Conversion Surgery for Unresectable Gastric Cancer with Splenic Metastasis and Splenic Vein Tumor Thrombus: A Case Report;Current Oncology;2024-05-08
3. International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape;Gastric Cancer;2024-04-18
4. Efficacy and safety of conversion therapy with Fluorouracil, Leucovorin, Oxaliplatin and Docetaxel (FLOT) in unresectable advanced gastric cancer;2023-12-13
5. Clinical outcomes of conversion surgery following immune checkpoint inhibitors and chemotherapy in stage IV gastric cancer;International Journal of Surgery;2023-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3